AdvaMed Calls for Tweaks to FDA Guidance on Inspections
October 24, 2019 “The current wording of the draft guidance…provides FDA with so much flexibility to deviate from these processes and standards that they are rendered meaningless,” writes AdvaMed Senior Executive Vice President for Technology and Regulatory Affairs Janet Trunzo. The group seeks revisions that address “this shortcoming” and align with least burdensome principles. AdvaMed … Read more